Skip Nav Destination
First Edition
Research Article November 1 2024
Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads
Julian Thalhammer,Eric Jeziorski,Perrrine Marec-Berard,Mohamed-Aziz Barkaoui,Anne Pagnier,Pierre-Simon Rohrlich,Aurore Chevallier,Liana Carausu,Nathalie Aladjidi,Charlotte Rigaud,Amaury Leruste,Saba Azarnoush,Thomas Lauvray,Solenne Le Louet,Virginie Gandemer,Pauline Treguier,Ludovic Mansuy,Marlène Pasquet,Laura Olivier,Angélique Rome,Paul Saultier,Florentina Isfan,Cecile Renard,Valérie Li Thiao Te,Alexandra Salmon,Laurence Blanc,Wadih Abou Chahla,Anne Lambilliotte,Jean-Louis Louis Stephan,Frederic Geissmann,Julien Lejeune,Coralie Mallebranche,Yves Reguerre,Audrey Grain,Caroline Thomas,Zofia Hélias-Rodzewicz,Despina Moshous,Odile Fenneteau,Aurore Coulomb-L'hermine,Hélène Lapillonne,Geneviève de Saint Basile,Jean-Francois Emile,Sébastien Héritier,Jean Donadieu
Review Article November 1 2024
Long-term Outcomes of tyrosine kinase inhibitors in chronic myeloid leukemia
Letter November 1 2024
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML
Review Article October 30 2024
Current myeloproliferative neoplasm scoring systems for clinical practice
Letter October 30 2024
Long term follow-up of the STOPAGO study
Adrien Cottu,Stéphanie Guillet,Jean-François Viallard,Etienne Riviere,Stéphane Cheze,Delphine Gobert,Antoine Neel,Julie Graveleau,Jean-Pierre Marolleau,François Lefrere,Guillaume Moulis,Jean-Christophe Lega,Aline Moignet,Ailsa Robbins,Etienne Crickx,Emmanuelle Boutin,Nicolas Noel,Marion Malphettes,Lionel Galicier,Sylvain Audia,Bernard Bonnotte,Olivier Lambotte,Olivier Fain,Mathieu Gerfaud-Valentin,Louis Terriou,Nihal Martis,Anne-Sophie Morin,Antoinette Perlat,Thomas Le Gallou,Frédérique Roy-Peaud,Matthieu Puyade,Thibault Comont,Nicolas Limal, MD,Laetitia Languille,Marc Michel,Bertrand Godeau,Matthieu Mahevas
Research Article October 30 2024
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma
Jan Eckmann,Tanja Fauti,Marlene Biehl,Aintzane Zabaleta,Laura Blanco,Iva Lelios,Stefan Gottwald,Richard Rae,Stefanie Lechner,Christa Bayer,Quincy Dekempe,Franz Osl,Nadège Carrié,Sahar Kassem,Stefan Lorenz,Tony Christopeit,Alejandro Carpy,Alexander Bujotzek,Ann-Marie E. Bröske,Iryna Dekhtiarenko,Jan Attig,Leo Kunz,Floriana Cremasco,Roberto Adelfio,Georg Fertig,Stefan Dengl,Christian Gassner,Felix Bormann,Claudia Kirstenpfad,Thomas Emanuel Kraft,Sarah Diggelmann,Melanie Knobloch,Carina Hage,Romi Feddersen,Gordon Heidkamp,Thomas Pöschinger,Maud Lea Mayoux,Luise Bernasconi,Charles Dumontet,Felipe Prosper,Ludovic Martinet,Stephane Leclair,Wei Xu,Bruno Paiva,Christian Klein,Pablo Umaña
Research Article October 29 2024
Venetoclax Dose Escalation Rapidly Activates a BAFF/BCL-2 Survival Axis in Chronic Lymphocytic Leukemia
Meng-Xiao Luo,Tania Tan,Marie Trussart,Annika Poch,Minh-Hanh Thi Nguyen,Terence P. Speed,Damien G Hicks,Esther Bandala-Sanchez,Hongke Peng,Stephane Chappaz,Charlotte Slade,Daniel T Utzschneider,Rachel M Koldej,David Ritchie,Andreas Strasser,Rachel Thijssen,Matthew E Ritchie,Constantine Si Lun Tam,Geoffrey J Lindeman,David Ching Siang Huang, Professor,Thomas E Lew,Mary Ann Anderson,Andrew W Roberts,Charis E Teh,Daniel H D Gray
Research Article October 24 2024
Cryo-EM structure of the human native plasma coagulation factor XIII complex
Research Article October 24 2024
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies
Laurie H. Sehn,Nancy L. Bartlett,Matthew J. Matasar,Stephen J. Schuster,Sarit E. Assouline,Pratyush Giri,John Kuruvilla,Mazyar Shadman,Chan Y Cheah,Sascha Dietrich,Keith Fay,Matthew Ku,Loretta J. Nastoupil,Michael C. Wei,Shen Yin,Iris To,Derrick Kaufman,Antonia Kwan,Elicia Penuel,Christopher R. Bolen,Lihua Elizabeth Budde
Research Article October 23 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy
Rishika Prasad,Abdur Rehman,Lubna Rehman,Faezeh Darbaniyan,Viktoria Blumenberg,Maria-Luisa Schubert,Uria Mor,Eli Zamir,Sabine Schmidt,Tomo Hayase,Chang Chia-Chi,Lauren Kelley McDaniel,Ivonne Flores,Paolo Strati,Ranjit Nair,Dai Chihara,Luis E. Fayad,Sairah Ahmed,Swaminathan P. Iyer,Michael L Wang,Preetesh Jain,Loretta J. Nastoupil,Jason R Westin,Reetakshi Arora,Joel Gordon Turner,Fareed Khawaja,Ranran Wu,Jennifer B Dennison,Meghan Menges,Melanie Hidalgo-Vargas,Kayla M. Reid,Marco L. Davila,Peter Dreger,Felix Korell,Anita Schmitt,Mark R Tanner,Richard E. Champlin,Christopher R. Flowers,Elizabeth J Shpall,Samir Hanash,Sattva S. Neelapu,Michael Schmitt,Marion Subklewe,Johannes Fahrmann,Christoph Stein-Thoeringer,Eran Elinav,Michael D Jain,Eiko Hayase,Robert R Jenq,Neeraj Y Saini
Brief Report October 23 2024
CNS Relapse in High-Grade B-cell Lymphoma with MYC and BCL2 Rearrangements and Dark-Zone Signature-Expressing DLBCL
Brief Report October 23 2024
Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma
Research Article October 22 2024
Ascorbate deficiency increases quiescence and self-renewal in hematopoietic stem cells and multipotent progenitors
Research Article October 22 2024
Conserved helical motifs in the IKZF1 disordered region mediate NuRD interaction and transcriptional repression
Research Article October 22 2024
A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed/refractory acute myeloid leukemia
Research Article October 22 2024
Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation
Anita Kumar,Jacob D. Soumerai,Jeremy S Abramson,Jeffrey A. Barnes,Philip C Caron,Shalini Chhabra,Maria Chabowska,Ahmet Dogan,Lorenzo Falchi,Clare Grieve,J. Erika Haydu,Patrick Connor Johnson,Ashlee Joseph,Hailey Kelly,Alyssa Labarre,Jennifer K Lue,Rosalba Martignetti,Joanna Mi,Alison J Moskowitz,Colette N Owens,Sean Plummer,Madeline Puccio,Gilles A. Salles,Venkatraman E Seshan,Elizabeth Simkins,Natalie Slupe,Honglei Zhang,Andrew D. Zelenetz
Research Article October 22 2024
Genetic iron overload aggravates and pharmacological iron restriction improves MDS pathophysiology in a preclinical study
Review Article October 11 2024
How I Treat Older Patients with Ph/BCR-ABL-Negative Acute Lymphoblastic Leukemia
Research Article October 8 2024
Failure of metabolic checkpoint control during late-stage granulopoiesis drives neutropenia in reticular dysgenesis
Review Article October 7 2024
How I use Maintenance Therapy in Acute Myeloid Leukemia
Review Article October 7 2024
How I treat Blastic Plasmacytoid Dendritic Cell Neoplasm
Research Article October 7 2024
Single-cell analysis of the multiple myeloma microenvironment after gamma-secretase inhibition and CAR T-cell therapy
Research Article October 7 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia
Research Article October 4 2024
Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma
Surbhi Sidana,Krina K. Patel,Lauren C Peres,Radhika Bansal,Mehmet Hakan Kocoglu,Leyla Shune,Shebli Atrash,Kinaya Smith,Shonali Midha,Christopher J Ferreri,Binod Dhakal,Danai Dima,Patrick Costello,Charlotte Wagner,Ran Reshef,Hitomi Hosoya,Lekha Mikkilineni,Djordje Atanackovic,Saurabh Chhabra,Ricardo D Parrondo,Omar Nadeem,Hashim Mann,Nilesh Kalariya,Vanna Hovanky,Gabriel DeAvila,Ciara L Freeman,Frederick L Locke,Melissa Alsina,Sandy Wong,Megan M Herr,Myo Htut,Joseph P. McGuirk,Douglas W Sborov,Jack Khouri,Thomas Martin,Murali Janakiram,Yi Lin,Doris K Hansen
Review Article October 2 2024
How I Treat: Secondary Acute Myeloid Leukemia
Review Article October 2 2024
How I Treat Sickle Cell Disease with Gene Therapy
Review Article October 2 2024
How I Treat Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Research Article October 2 2024
Ex Vivo Venetoclax Sensitivity Predicts Clinical Response in Acute Myeloid Leukemia in the Prospective VenEx Trial
Sari Kytölä,Ida Maria Vänttinen,Tanja Ruokoranta,Anu Partanen,Annasofia Holopainen,Joseph Saad,Milla E.L. Kuusisto,Sirpa Koskela,Riikka Katariina Räty,Maija Itälä-Remes,Imre Västrik,Minna Suvela,Alun Owen Parsons,Kimmo Porkka,Krister Wennerberg,Caroline A. Heckman,Tero Jalkanen,Teppo Huttunen,Pia Ettala, MD,Johanna Rimpiläinen,Timo Siitonen,Marja Pyörälä,Heikki Kuusanmäki,Mika Kontro
Research Article September 27 2024
Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study
Ashraf Z Badros,Laahn Foster,Larry D. Anderson, Jr.,Chakra P. Chaulagain,Erin M Pettijohn,Andrew J Cowan,Caitlin L. Costello,Sarah Larson,Douglas W Sborov,Kenneth H Shain,Rebecca Silbermann,Nina Shah,Alfred Chung,Maria Krevvata,Huiling Pei,Sharmila Patel,Vipin Khare,Annelore Cortoos,Robin Carson,Thomas Lin,Peter M Voorhees
Research Article September 25 2024
Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis
Research Article September 24 2024
Outcomes in patients with ETV6::RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies
Research Article September 24 2024
Sustained Benefit of Zanubrutinib vs Ibrutinib in Patients With R/R CLL/SLL: Final Comparative Analysis of ALPINE
Jennifer R. Brown,Barbara Eichhorst,Nicole Lamanna,Susan M O'Brien, M.D.,Constantine S. Tam,Lugui Qiu,Wojciech Jurczak,Keshu Zhou,Martin Šimkovič,Jiří Mayer,Amanda Gillespie-Twardy,Alessandra Ferrajoli,Peter Stephen Ganly,Robert Weinkove,Sebastian Grosicki,Andrzej Mital,Tadeusz Robak, Prof.,Anders Osterborg,Habte A. Yimer,Megan (Der Yu) Wang,Tommi Salmi,Liping Wang,Jessica Li,Kenneth Wu,Aileen Cleary Cohen,Mazyar Shadman
Review Article September 24 2024
The present and future for CAR-T cell therapy in adult B-cell ALL
Review Article September 24 2024
The current landscape of frontline large B-cell lymphoma trials
Review Article September 24 2024
How I Treat patients with AML using azacitidine and venetoclax
Review Article September 18 2024
Management of iron overload: lessons from transfusion-dependent hemoglobinopathies
Review Article September 5 2024
TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
